Camille Vatier

4.9k total citations
56 papers, 776 citations indexed

About

Camille Vatier is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Camille Vatier has authored 56 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 17 papers in Epidemiology and 16 papers in Physiology. Recurrent topics in Camille Vatier's work include Nuclear Structure and Function (24 papers), RNA Research and Splicing (15 papers) and Adipokines, Inflammation, and Metabolic Diseases (13 papers). Camille Vatier is often cited by papers focused on Nuclear Structure and Function (24 papers), RNA Research and Splicing (15 papers) and Adipokines, Inflammation, and Metabolic Diseases (13 papers). Camille Vatier collaborates with scholars based in France, Spain and United Kingdom. Camille Vatier's co-authors include Corinne Vigouroux, Jacqueline Capeau, Olivier Lascols, Isabelle Jéru, Sophie Christin‐Maître, Bruno Fève, Guillaume Bidault, Véronique Béréziat, Nolwenn Briand and Martine Auclair and has published in prestigious journals such as Blood, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Camille Vatier

53 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Camille Vatier France 18 380 204 120 113 91 56 776
Lucie Šedová Czechia 18 305 0.8× 169 0.8× 114 0.9× 127 1.1× 153 1.7× 50 692
Helena A. Jones Sweden 12 532 1.4× 281 1.4× 164 1.4× 130 1.2× 136 1.5× 14 891
Maryam Zarkesh Iran 17 205 0.5× 153 0.8× 77 0.6× 102 0.9× 225 2.5× 95 754
Odile Fabre France 14 560 1.5× 272 1.3× 111 0.9× 81 0.7× 40 0.4× 28 865
Darko Stevanović Serbia 17 487 1.3× 364 1.8× 146 1.2× 77 0.7× 122 1.3× 26 1.2k
Saja S. Khuder United States 12 277 0.7× 165 0.8× 114 0.9× 125 1.1× 169 1.9× 17 614
Mark Nixon United Kingdom 14 141 0.4× 231 1.1× 73 0.6× 82 0.7× 187 2.1× 42 741
Jacobie Steenbergen Netherlands 19 246 0.6× 281 1.4× 107 0.9× 98 0.9× 267 2.9× 31 927
Sina Kavalakatt Kuwait 15 247 0.7× 253 1.2× 79 0.7× 58 0.5× 148 1.6× 27 763
Ruxing Zhao China 15 183 0.5× 147 0.7× 116 1.0× 73 0.6× 111 1.2× 28 602

Countries citing papers authored by Camille Vatier

Since Specialization
Citations

This map shows the geographic impact of Camille Vatier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camille Vatier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camille Vatier more than expected).

Fields of papers citing papers by Camille Vatier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camille Vatier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camille Vatier. The network helps show where Camille Vatier may publish in the future.

Co-authorship network of co-authors of Camille Vatier

This figure shows the co-authorship network connecting the top 25 collaborators of Camille Vatier. A scholar is included among the top collaborators of Camille Vatier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camille Vatier. Camille Vatier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vantyghem, Marie‐Christine, Estelle Nobécourt, Héléna Mosbah, et al.. (2025). Safety and effectiveness in an uncontrolled setting of glucagon‐like‐peptide‐1 receptor agonists in patients with familial partial lipodystrophy: Real‐life experience from a national reference network. Diabetes Obesity and Metabolism. 27(4). 1815–1825. 4 indexed citations
2.
Bastard, Jean‐Philippe, et al.. (2024). Biological markers of adipose tissue: Adipokines. Annales d Endocrinologie. 85(3). 171–172. 4 indexed citations
3.
Vatier, Camille, Émilie Capel, Martine Auclair, et al.. (2022). Molecular and Cellular Bases of Lipodystrophy Syndromes. Frontiers in Endocrinology. 12. 803189–803189. 53 indexed citations
4.
Vatier, Camille, Sophie Christin‐Maître, & Corinne Vigouroux. (2022). Role of insulin resistance on fertility – Focus on polycystic ovary syndrome. Annales d Endocrinologie. 83(3). 199–202. 12 indexed citations
5.
Cuerq, Charlotte, Gilles Morineau, Diane Dufour‐Rainfray, et al.. (2020). Mutltifaceted biological roles of adiponectin. Annales de biologie clinique. 78(3). 243–252. 4 indexed citations
6.
Vatier, Camille, Bárbara Antuna-Puente, Soraya Fellahi, et al.. (2020). The adiponectin to leptin ratio, a still unrecognized biomarker of insulin resistance and cardiometabolic risk. Annales de biologie clinique. 78(3). 265–268. 7 indexed citations
7.
Dufour‐Rainfray, Diane, Gilles Morineau, Camille Vatier, et al.. (2020). Mutltifaceted biological roles of leptin. Annales de biologie clinique. 78(3). 231–242. 4 indexed citations
8.
Bourguet, William, Corinne Vigouroux, Camille Vatier, et al.. (2020). Peroxisome proliferator‐activated receptor gamma‐ligand‐binding domain mutations associated with familial partial lipodystrophy type 3 disrupt human trophoblast fusion and fibroblast migration. Journal of Cellular and Molecular Medicine. 24(13). 7660–7669. 9 indexed citations
9.
Mosbah, Héléna, Camille Vatier, Franck Boccara, et al.. (2020). Cardiovascular complications of lipodystrophic syndromes – focus on laminopathies. Annales d Endocrinologie. 82(3-4). 146–148. 1 indexed citations
10.
Vatier, Camille, Émilie Capel, Olivier Lascols, et al.. (2019). Lipodystrophic syndromes: From diagnosis to treatment. Annales d Endocrinologie. 81(1). 51–60. 20 indexed citations
11.
Vatier, Camille, Isabelle Jéru, Philippe Latour, et al.. (2017). Homozygous p.R707W MFN2 mutation is associated with neuropathy, lipomatosis, peripheral lipoatrophy and metabolic alterations. Neuromuscular Disorders. 27. S148–S148. 3 indexed citations
12.
Jéru, Isabelle, Camille Vatier, David Araújo‐Vilar, Corinne Vigouroux, & Olivier Lascols. (2016). Clinical Utility Gene Card for: Familial partial lipodystrophy. European Journal of Human Genetics. 25(2). 271–271. 16 indexed citations
13.
14.
Repessé, Xavier, Marthe Moldes, Adeline Muscat, et al.. (2015). Hypoxia inhibits semicarbazide-sensitive amine oxidase activity in adipocytes. Molecular and Cellular Endocrinology. 411. 58–66. 8 indexed citations
15.
Mitrovic, Stéphane, L. Fardet, Camille Vatier, et al.. (2014). THU0142 Safety of Glucocorticoids for Early Rheumatoid Arthritis: A Meta-Analysis of Randomised Controlled Trials. Annals of the Rheumatic Diseases. 73. 228–228. 1 indexed citations
16.
Briand, Nolwenn, Guillaume Bidault, Véronique Béréziat, et al.. (2014). Nuclear envelope-related lipodystrophies. Seminars in Cell and Developmental Biology. 29. 148–157. 54 indexed citations
17.
Vatier, Camille, Guillaume Bidault, Nolwenn Briand, et al.. (2013). What the Genetics of Lipodystrophy Can Teach Us About Insulin Resistance and Diabetes. Current Diabetes Reports. 13(6). 757–767. 23 indexed citations
18.
Vatier, Camille, Corneliu Hénégar, Cécile Ciangura, et al.. (2012). Dynamic Relations Between Sedentary Behavior, Physical Activity, and Body Composition After Bariatric Surgery. Obesity Surgery. 22(8). 1251–1256. 53 indexed citations
19.
Vatier, Camille, et al.. (2010). Glyceroneogenesis is inhibited through HIV protease inhibitor-induced inflammation in human subcutaneous but not visceral adipose tissue. Journal of Lipid Research. 52(2). 207–220. 19 indexed citations
20.
Vatier, Camille, Jacqueline Capeau, & Corinne Vigouroux. (2010). La leptine, nouvelle perspective thérapeutique dans le traitement du diabète ?. médecine/sciences. 26(10). 803–807. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucie Šedová Breakdown of academic impact, for papers by Helena A. Jones Breakdown of academic impact, for papers by Maryam Zarkesh Breakdown of academic impact, for papers by Odile Fabre Breakdown of academic impact, for papers by Darko Stevanović Breakdown of academic impact, for papers by Saja S. Khuder Breakdown of academic impact, for papers by Mark Nixon Breakdown of academic impact, for papers by Jacobie Steenbergen Breakdown of academic impact, for papers by Sina Kavalakatt Breakdown of academic impact, for papers by Ruxing Zhao
Rankless by CCL
2026